the celestine clinic limited
the celestine clinic limited Company Information
Company Number
10386169
Next Accounts
Jun 2025
Industry
Other human health activities
Directors
Shareholders
jackie hales
Group Structure
View All
Contact
Registered Address
marwood house stones cross road, crockenhill, swanley, BR8 8LT
Website
www.thecelestineclinic.comthe celestine clinic limited Estimated Valuation
Pomanda estimates the enterprise value of THE CELESTINE CLINIC LIMITED at £54k based on a Turnover of £94.8k and 0.57x industry multiple (adjusted for size and gross margin).
the celestine clinic limited Estimated Valuation
Pomanda estimates the enterprise value of THE CELESTINE CLINIC LIMITED at £0 based on an EBITDA of £-8.8k and a 4.36x industry multiple (adjusted for size and gross margin).
the celestine clinic limited Estimated Valuation
Pomanda estimates the enterprise value of THE CELESTINE CLINIC LIMITED at £18.3k based on Net Assets of £7.4k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Celestine Clinic Limited Overview
The Celestine Clinic Limited is a live company located in swanley, BR8 8LT with a Companies House number of 10386169. It operates in the other human health activities sector, SIC Code 86900. Founded in September 2016, it's largest shareholder is jackie hales with a 100% stake. The Celestine Clinic Limited is a young, micro sized company, Pomanda has estimated its turnover at £94.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Celestine Clinic Limited Health Check
Pomanda's financial health check has awarded The Celestine Clinic Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
8 Weak
Size
annual sales of £94.8k, make it smaller than the average company (£678.9k)
- The Celestine Clinic Limited
£678.9k - Industry AVG
Growth
3 year (CAGR) sales growth of -7%, show it is growing at a slower rate (5.8%)
- The Celestine Clinic Limited
5.8% - Industry AVG
Production
with a gross margin of 36.8%, this company has a comparable cost of product (36.8%)
- The Celestine Clinic Limited
36.8% - Industry AVG
Profitability
an operating margin of -9.7% make it less profitable than the average company (5.7%)
- The Celestine Clinic Limited
5.7% - Industry AVG
Employees
with 3 employees, this is below the industry average (18)
3 - The Celestine Clinic Limited
18 - Industry AVG
Pay Structure
on an average salary of £25.3k, the company has an equivalent pay structure (£25.3k)
- The Celestine Clinic Limited
£25.3k - Industry AVG
Efficiency
resulting in sales per employee of £31.6k, this is less efficient (£46.6k)
- The Celestine Clinic Limited
£46.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- The Celestine Clinic Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 1 days, this is quicker than average (18 days)
- The Celestine Clinic Limited
18 days - Industry AVG
Stock Days
it holds stock equivalent to 2 days, this is less than average (11 days)
- The Celestine Clinic Limited
11 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 62 weeks, this is less cash available to meet short term requirements (111 weeks)
62 weeks - The Celestine Clinic Limited
111 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 82.2%, this is a higher level of debt than the average (25.6%)
82.2% - The Celestine Clinic Limited
25.6% - Industry AVG
THE CELESTINE CLINIC LIMITED financials
The Celestine Clinic Limited's latest turnover from September 2023 is estimated at £94.8 thousand and the company has net assets of £7.4 thousand. According to their latest financial statements, The Celestine Clinic Limited has 3 employees and maintains cash reserves of £29.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | |||||||
| Interest Receivable | |||||||
| Pre-Tax Profit | |||||||
| Tax | |||||||
| Profit After Tax | |||||||
| Dividends Paid | |||||||
| Retained Profit | |||||||
| Employee Costs | |||||||
| Number Of Employees | 3 | 4 | 4 | 3 | 4 | 3 | 2 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,470 | 2,869 | 3,126 | 3,678 | 4,327 | 5,136 | 5,297 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 2,470 | 2,869 | 3,126 | 3,678 | 4,327 | 5,136 | 5,297 |
| Stock & work in progress | 389 | 414 | 255 | 270 | 285 | 322 | 560 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 9,309 | 23 | 23 | 518 | 0 | 0 | 0 |
| Cash | 29,579 | 46,475 | 39,174 | 55,516 | 47,446 | 36,173 | 28,902 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 39,277 | 46,912 | 39,452 | 56,304 | 47,731 | 36,495 | 29,462 |
| total assets | 41,747 | 49,781 | 42,578 | 59,982 | 52,058 | 41,631 | 34,759 |
| Bank overdraft | 5,000 | 5,000 | 5,000 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 287 | 0 | 0 | 0 | 0 | 1,026 | 1,944 |
| Group/Directors Accounts | 0 | 369 | 89 | 2,610 | 583 | 975 | 778 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 19,448 | 13,237 | 11,007 | 7,623 | 18,255 | 18,429 | 23,649 |
| total current liabilities | 24,735 | 18,606 | 16,096 | 10,233 | 18,838 | 20,430 | 26,371 |
| loans | 9,583 | 14,583 | 19,583 | 25,000 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 9,583 | 14,583 | 19,583 | 25,000 | 0 | 0 | 0 |
| total liabilities | 34,318 | 33,189 | 35,679 | 35,233 | 18,838 | 20,430 | 26,371 |
| net assets | 7,429 | 16,592 | 6,899 | 24,749 | 33,220 | 21,201 | 8,388 |
| total shareholders funds | 7,429 | 16,592 | 6,899 | 24,749 | 33,220 | 21,201 | 8,388 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | 399 | 506 | 552 | 649 | 809 | 907 | 935 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||
| Stock | -25 | 159 | -15 | -15 | -37 | -238 | 560 |
| Debtors | 9,286 | 0 | -495 | 518 | 0 | 0 | 0 |
| Creditors | 287 | 0 | 0 | 0 | -1,026 | -918 | 1,944 |
| Accruals and Deferred Income | 6,211 | 2,230 | 3,384 | -10,632 | -174 | -5,220 | 23,649 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -369 | 280 | -2,521 | 2,027 | -392 | 197 | 778 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -5,000 | -5,000 | -5,417 | 25,000 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||
| interest | |||||||
| cash flow from financing | |||||||
| cash and cash equivalents | |||||||
| cash | -16,896 | 7,301 | -16,342 | 8,070 | 11,273 | 7,271 | 28,902 |
| overdraft | 0 | 0 | 5,000 | 0 | 0 | 0 | 0 |
| change in cash | -16,896 | 7,301 | -21,342 | 8,070 | 11,273 | 7,271 | 28,902 |
the celestine clinic limited Credit Report and Business Information
The Celestine Clinic Limited Competitor Analysis
Perform a competitor analysis for the celestine clinic limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in BR8 area or any other competitors across 12 key performance metrics.
the celestine clinic limited Ownership
THE CELESTINE CLINIC LIMITED group structure
The Celestine Clinic Limited has no subsidiary companies.
Ultimate parent company
THE CELESTINE CLINIC LIMITED
10386169
the celestine clinic limited directors
The Celestine Clinic Limited currently has 1 director, Mrs Jackie Hales serving since Sep 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Jackie Hales | United Kingdom | 77 years | Sep 2016 | - | Director |
P&L
September 2023turnover
94.8k
-43%
operating profit
-9.2k
0%
gross margin
36.8%
-0.59%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
7.4k
-0.55%
total assets
41.7k
-0.16%
cash
29.6k
-0.36%
net assets
Total assets minus all liabilities
Similar Companies
the celestine clinic limited company details
company number
10386169
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
September 2016
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
AR GARDINER & CO. LTD
auditor
-
address
marwood house stones cross road, crockenhill, swanley, BR8 8LT
Bank
-
Legal Advisor
-
the celestine clinic limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the celestine clinic limited.
the celestine clinic limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE CELESTINE CLINIC LIMITED. This can take several minutes, an email will notify you when this has completed.
the celestine clinic limited Companies House Filings - See Documents
| date | description | view/download |
|---|
